These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 3318824

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Improvement of potential therapeutic value of tumor necrosis-alpha (TNF-alpha) by charge modulation in the tip region.
    Fonda I, Pernus M, Gaberc-Porekar V, Kenig M, Stalc A, Meager A, Menart V.
    Eur Cytokine Netw; 2005; 16(1):17-26. PubMed ID: 15809202
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Recombinant tumour necrosis factor (TNF) fixed to cell monolayers retains its cytotoxic and growth-stimulatory activity. Evidence that internalization of TNF is not necessary for induction of biological effects.
    Hofsli E, Nissen-Meyer J.
    Scand J Immunol; 1989 Jan; 29(1):57-63. PubMed ID: 2537996
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Tandem arrangement of genes coding for tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) in the human genome.
    Nedospasov SA, Shakhov AN, Turetskaya RL, Mett VA, Azizov MM, Georgiev GP, Korobko VG, Dobrynin VN, Filippov SA, Bystrov NS.
    Cold Spring Harb Symp Quant Biol; 1986 Jan; 51 Pt 1():611-24. PubMed ID: 3555974
    [No Abstract] [Full Text] [Related]

  • 30. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro.
    Tomazic VJ, Farha M, Loftus A, Elias EG.
    J Immunol; 1988 Jun 01; 140(11):4056-61. PubMed ID: 3372997
    [Abstract] [Full Text] [Related]

  • 31. Tumor necrosis factor and interleukin-1 protection against the lethal effects of tumor necrosis factor.
    Sheppard BC, Norton JA.
    Surgery; 1991 Jun 01; 109(6):698-705. PubMed ID: 2042087
    [Abstract] [Full Text] [Related]

  • 32. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
    Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A, Figari IS, Palladino MA, O'Connor JV.
    J Exp Med; 1986 Jun 01; 163(6):1433-50. PubMed ID: 3486936
    [Abstract] [Full Text] [Related]

  • 33. Efficient purification of recombinant human tumor necrosis factor beta from Escherichia coli yields biologically active protein with a trimeric structure that binds to both tumor necrosis factor receptors.
    Schoenfeld HJ, Poeschl B, Frey JR, Loetscher H, Hunziker W, Lustig A, Zulauf M.
    J Biol Chem; 1991 Feb 25; 266(6):3863-9. PubMed ID: 1847389
    [Abstract] [Full Text] [Related]

  • 34. Human recombinant tumor necrosis factor alpha infusion mimics endotoxemia in awake sheep.
    Johnson J, Meyrick B, Jesmok G, Brigham KL.
    J Appl Physiol (1985); 1989 Mar 25; 66(3):1448-54. PubMed ID: 2708260
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Regulation of B cell maturation and differentiation. I. Suppression of pokeweed mitogen-induced B cell differentiation by tumor necrosis factor (TNF).
    Kashiwa H, Wright SC, Bonavida B.
    J Immunol; 1987 Mar 01; 138(5):1383-90. PubMed ID: 2949015
    [Abstract] [Full Text] [Related]

  • 37. Novel muteins of human tumor necrosis factor alpha.
    Ito R, Matsumoto H, Uchida K, Kubo T, Tsukii Y, Endo T, Kaji A.
    Biochim Biophys Acta; 1991 Apr 15; 1096(3):245-52. PubMed ID: 2018798
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.